See All Slides - tctmd.com

Slides

Presentation TCT 2023

PROs are a Powerful Endpoint in TR Interventional Trials

Presenter: Suzanne Arnold

October 25, 2023

Presentation TCT 2023

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Presenter: Juan Granada

October 25, 2023

Presentation TCT 2023

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Presenter: Isaac George

October 25, 2023

Presentation TCT 2023

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Presenter: Azeem Latib

October 25, 2023

Presentation TCT 2023

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

Presenter: David Tryon

October 25, 2023

Presentation TCT 2023

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

Presenter: Alexandre Abizaid

October 25, 2023

Presentation TCT 2023

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Presenter: Stefan Verheye

October 25, 2023

Presentation TCT 2023

Completeness of Revascularization by FFRCT: Association to Patient- and Vessel-Oriented Cardiac Outcomes

Presenter: Kristian Taekker Madsen

October 25, 2023

Presentation TCT 2023

Safety and Feasibility of Planning and Performing Coronary Artery Bypass Surgery Guided Solely by Coronary Computed Tomography Angiography

Presenter: Patrick Serruys

October 25, 2023

Presentation TCT 2023

Artificial Intelligence-Enabled Quantitative Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome Risk and Prevention Strategy: The EMERALD II Study

Presenter: Bon-Kwon Koo

October 25, 2023

Advertisement

Slides

PROs are a Powerful Endpoint in TR Interventional Trials

Second Wave Technology Will Solve Most Problems – TMVR is Here to Stay in a Big Way!

Screen Failures, Technology Woes, Lack of Clinical Evidence, and Difficult Clinical Trial Pathways – TMVR is No More than a Niche!

Results from the Early Human Experience with the Supira Percutaneous Ventricular Assist Device (Supira Medical)

Coronary Sinus Reducer Improves Angina and Coronary Flow Reserve in Patients With Coronary Microvascular Dysfunction

First Human Use of a ‘Hybrid’ (Polymer + Metal) Coronary Drug-Eluting Stent: The IonMAN Study

A Randomized Clinical Trial of a Novel Triple Drug Eluting Coronary Implant Eluting Two Anticoagulants and Sirolimus: Six-Month Clinical and Imaging Results of the DESyne BDS Plus Study

Completeness of Revascularization by FFRCT: Association to Patient- and Vessel-Oriented Cardiac Outcomes

Safety and Feasibility of Planning and Performing Coronary Artery Bypass Surgery Guided Solely by Coronary Computed Tomography Angiography

Artificial Intelligence-Enabled Quantitative Plaque and Hemodynamic Analysis for Predicting Acute Coronary Syndrome Risk and Prevention Strategy: The EMERALD II Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content